Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Craig T. Jordan

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Jordan, Craig

One or more keywords matched the following items that are connected to Jordan, Craig

Item Type	Name
Academic Article	Considerations for targeting malignant stem cells in leukemia.
Academic Article	Feverfew: weeding out the root of leukaemia.
Academic Article	The potential of targeting malignant stem cells as a treatment for leukemia.
Academic Article	The leukemic stem cell.
Academic Article	Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.
Academic Article	Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-kappaB inhibitor, DMAPT (LC-1).
Academic Article	Melampomagnolide B: a new antileukemic sesquiterpene.
Academic Article	Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell lines.
Academic Article	Targeting the most critical cells: approaching leukemia therapy as a problem in stem cell biology.
Academic Article	The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.
Academic Article	The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine.
Academic Article	Protein kinase C-associated kinase is required for NF-kappaB signaling and survival in diffuse large B-cell lymphoma cells.
Academic Article	Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104.
Concept	Antineoplastic Agents
Concept	Antineoplastic Agents, Phytogenic
Academic Article	Gene signature critical to cancer phenotype as a paradigm for anticancer drug discovery.
Academic Article	Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalization.
Academic Article	Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia.
Academic Article	Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials.
Academic Article	Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity.
Academic Article	Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia.
Academic Article	Dimers of Melampomagnolide B Exhibit Potent Anticancer Activity against Hematological and Solid Tumor Cells.
Academic Article	Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche.
Academic Article	Chemoenzymatic synthesis and antileukemic activity of novel C9- and C14-functionalized parthenolide analogs.
Academic Article	ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia.
Academic Article	Identification of a melampomagnolide B analog as a potential lead molecule for treatment of acute myelogenous leukemia.
Academic Article	Design, synthesis and evaluation of anti-CD123 antibody drug conjugates.
Academic Article	Indole carboxylic acid esters of melampomagnolide B are potent anticancer agents against both hematological and solid tumor cells.
Academic Article	Succinamide derivatives of melampomagnolide B and their anti-cancer activities.
Academic Article	MMB triazole analogs are potent NF-?B inhibitors and anti-cancer agents against both hematological and solid tumor cells.
Academic Article	Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells.
Academic Article	Targeting Glutamine Metabolism and Redox State for Leukemia Therapy.
Academic Article	Can we selectively target AML stem cells?
Academic Article	Substituted oxindol-3-ylidenes as AMP-activated protein kinase (AMPK) inhibitors.
Academic Article	Antitumor properties of novel sesquiterpene lactone analogs as NF?B inhibitors that bind to the IKK? ubiquitin-like domain (ULD).

Search Criteria

Antineoplastic Agents